Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cardinal Health (CAH)

Cardinal Health (CAH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,488,296
  • Shares Outstanding, K 241,568
  • Annual Sales, $ 226,827 M
  • Annual Income, $ 852,000 K
  • EBIT $ 2,228 M
  • EBITDA $ 2,938 M
  • 60-Month Beta 0.63
  • Price/Sales 0.14
  • Price/Cash Flow 12.03
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 21.24% ( +0.99%)
  • Historical Volatility 19.51%
  • IV Percentile 33%
  • IV Rank 30.69%
  • IV High 35.81% on 08/05/24
  • IV Low 14.79% on 12/04/24
  • Put/Call Vol Ratio 0.36
  • Today's Volume 2,492
  • Volume Avg (30-Day) 5,565
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 47,229
  • Open Int (30-Day) 42,509

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 2.15
  • Number of Estimates 8
  • High Estimate 2.22
  • Low Estimate 2.04
  • Prior Year 2.08
  • Growth Rate Est. (year over year) +3.37%

Price Performance

See More
Period Period Low Period High Performance
1-Month
122.49 +3.04%
on 01/15/25
132.84 -4.99%
on 01/30/25
+2.18 (+1.76%)
since 01/14/25
3-Month
114.60 +10.13%
on 12/17/24
132.84 -4.99%
on 01/30/25
+4.92 (+4.06%)
since 11/14/24
52-Week
93.17 +35.46%
on 07/15/24
132.84 -4.99%
on 01/30/25
+22.66 (+21.88%)
since 02/14/24

Most Recent Stories

More News
DVA Stock Down in Pre-Market Despite Q4 Earnings Beat, Margins Expand

DaVita Inc. DVA delivered adjusted earnings per share (EPS) of $2.24 in the fourth quarter of 2024, up 19.8% year over year. The figure surpassed the Zacks Consensus Estimate by 1.4%.Find the latest EPS...

BSX : 106.11 (-0.03%)
RMD : 232.98 (-2.71%)
CAH : 126.21 (-0.45%)
DVA : 157.42 (-11.09%)
WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down

West Pharmaceutical Services, Inc. WST delivered adjusted earnings per share (EPS) of $1.82 in the fourth quarter of 2024, down by a penny year over year. The figure topped the Zacks Consensus Estimate...

BSX : 106.11 (-0.03%)
RMD : 232.98 (-2.71%)
WST : 214.73 (+7.84%)
CAH : 126.21 (-0.45%)
EW Stock Up on Q4 Earnings and Revenue Beat, Margins Crash

Edwards Lifesciences Corporation EW reported fourth-quarter 2024 adjusted earnings per share (EPS) of 59 cents, which surpassed the Zacks Consensus Estimate by 7.3%. The figure increased 7.3% from the...

EW : 76.19 (+0.25%)
DGX : 168.77 (+0.03%)
RMD : 232.98 (-2.71%)
CAH : 126.21 (-0.45%)
ECL Stock Up in Pre-Market Following Q4 Earnings Beat, Margins Expand

Ecolab Inc. ECL reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.81, up 16.8% year over year. The bottom line exceeded the Zacks Consensus Estimate by 1.1%.Find the latest EPS estimates...

BSX : 106.11 (-0.03%)
RMD : 232.98 (-2.71%)
CAH : 126.21 (-0.45%)
ECL : 264.74 (-0.27%)
Should You Buy, Hold or Sell MCK Stock Following Robust Q3 Earnings?

McKesson MCK delivered an 18% increase in revenues ($95.3 billion) and a 16% rise in adjusted operating profit during the third quarter of fiscal 2025 despite ongoing macroeconomic challenges. The company...

MCK : 593.69 (-1.46%)
COR : 242.63 (-0.55%)
CAH : 126.21 (-0.45%)
Are Wall Street Analysts Predicting Cardinal Health Stock Will Climb or Sink?

Cardinal Health has observed a notable surge in stock prices recently and received several ratings upgrades shifting the consensus to a "Strong Buy."

XHS : 100.57 (-0.76%)
$SPX : 6,114.63 (-0.01%)
CAH : 126.21 (-0.45%)
ILMN Q4 Earnings Miss Estimates, Stock Dips in Aftermarket

Illumina Inc. ILMN reported fourth-quarter 2024 adjusted earnings per share (EPS) of 86 cents, which missed the Zacks Consensus Estimate of 92 cents by 6.5%. The bottom line was significantly above the...

DGX : 168.77 (+0.03%)
ILMN : 100.24 (-1.51%)
RMD : 232.98 (-2.71%)
CAH : 126.21 (-0.45%)
ZBH's Q4 Earnings Beat, Margins Contract, Stock Down in Premarket

Zimmer Biomet Holdings, Inc. ZBH posted fourth-quarter 2024 adjusted earnings per share (EPS) of $2.31, beating the Zacks Consensus Estimate by a penny. The adjusted figure increased 5% year over year.See...

ZBH : 100.52 (+0.61%)
DGX : 168.77 (+0.03%)
RMD : 232.98 (-2.71%)
CAH : 126.21 (-0.45%)
STE Q3 Earnings In Line, '25 Sales View Cut, Stock Up in Aftermarket

STERIS plc STE reported third-quarter fiscal 2025 adjusted earnings per share (EPS) of $2.32, up 9.9% from the year-ago quarter’s figure. The figure is in line with the Zacks Consensus Estimate. Find...

DGX : 168.77 (+0.03%)
STE : 219.34 (+0.05%)
RMD : 232.98 (-2.71%)
CAH : 126.21 (-0.45%)
ALGN Q4 Earnings Top Estimates, Revenues Miss, Stock Falls

Align Technology, Inc. ALGN delivered fourth-quarter 2024 adjusted earnings per share (EPS) of $2.44, up 0.8% from the year-ago level. The reported figure topped the Zacks Consensus Estimate by 0.4%.Find...

DGX : 168.77 (+0.03%)
RMD : 232.98 (-2.71%)
CAH : 126.21 (-0.45%)
ALGN : 206.77 (+0.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and...

See More

Key Turning Points

3rd Resistance Point 129.09
2nd Resistance Point 128.50
1st Resistance Point 127.35
Last Price 126.21
1st Support Level 125.61
2nd Support Level 125.02
3rd Support Level 123.87

See More

52-Week High 132.84
Last Price 126.21
Fibonacci 61.8% 117.69
Fibonacci 50% 113.00
Fibonacci 38.2% 108.32
52-Week Low 93.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar